 |
58 Diseases |  |
27 Trials |
|
27 Trials |  |
1449 News |  |
| «123456789101112» |
- oxycodone controlled release / Generic mfg.
New trial: Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy (clinicaltrials.gov) - Feb 7, 2017
P=N/A, N=130, Recruiting, Sponsor: Sun Yat-sen University
- New P3 trial: Rebound Pain After Operations for Distal Radius Fractures With a Volar Plate in Brachial Plexus Block (clinicaltrials.gov) - Jan 5, 2017
P3, N=50, Not yet recruiting, Sponsor: Oslo University Hospital
- | dextromethorphan / Generic mfg.
New P4 trial: Dextromethorphan Use in Multimodal Analgesia Regimens for Total Knee Arthroplasty (clinicaltrials.gov) - Dec 9, 2016
P4, N=60, Not yet recruiting, Sponsor: University of Southern California
- oxycodone ER (PF614) / Ensysce Biosciences
Enrollment open, Enrollment change, Trial initiation date, Trial primary completion date: Study of PF614 Compared to OxyContin (clinicaltrials.gov) - Dec 1, 2016
P1, N=48, Recruiting, Sponsor: Signature Therapeutics
Not yet recruiting --> Recruiting | N=60 --> 48 | Initiation date: Aug 2015 --> Nov 2016 | Trial primary completion date: Jan 2016 --> Mar 2017
- Gralise (gabapentin) / Alvogen
Trial primary completion date, HEOR: Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation (clinicaltrials.gov) - Nov 29, 2016
P=N/A, N=60, Recruiting, Sponsor: Roswell Park Cancer Institute
Not yet recruiting --> Recruiting | N=60 --> 48 | Initiation date: Aug 2015 --> Nov 2016 | Trial primary completion date: Jan 2016 --> Mar 2017 Trial primary completion date: Jan 2017 --> Jan 2021
- oxycodone controlled release / Generic mfg., ibuprofen / Generic mfg.
Biomarker, New trial: Utility of Pharmacogenomic Testing and Postoperative Dental Pain Outcomes (clinicaltrials.gov) - Oct 13, 2016
P=N/A, N=238, Not yet recruiting, Sponsor: University of Rochester
- Enrollment open, HEOR, Surgery: CES_SNS_LBP: Comparative Effectiveness Study for Surgery vs. Non-Surgery in Patients With Low Back Pain (clinicaltrials.gov) - Sep 29, 2016
P=N/A, N=1102, Recruiting, Sponsor: Seoul National University Hospital
Trial primary completion date: Jan 2017 --> Jan 2021 Not yet recruiting --> Recruiting
- New trial, HEOR, Surgery: CES_SNS_LBP: Comparative Effectiveness Study for Surgery vs. Non-Surgery in Patients With Low Back Pain (clinicaltrials.gov) - Sep 9, 2016
P=N/A, N=1102, Recruiting, Sponsor: Seoul National University Hospital
- |||||| OxiFast (oxycodone immediate release) / Purdue, Shionogi, Mundipharma
Enrollment open, Surgery: Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway (clinicaltrials.gov) - Sep 6, 2016
P3, N=200, Recruiting, Sponsor: M.D. Anderson Cancer Center
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Gralise (gabapentin) / Alvogen
Enrollment change, HEOR: Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation (clinicaltrials.gov) - Aug 1, 2016
P=N/A, N=60, Recruiting, Sponsor: Roswell Park Cancer Institute
Not yet recruiting --> Recruiting N=30 --> 60
- |||||||||| OxiFast (oxycodone immediate release) / Purdue, Shionogi, Mundipharma
New P3 trial, Surgery: Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway (clinicaltrials.gov) - Apr 15, 2016
P3, N=200, Not yet recruiting, Sponsor: M.D. Anderson Cancer Center
- Oxecta (oxycodone) / Assertio
Enrollment change, Trial withdrawal, Trial primary completion date: Clinical Evaluation of the ReLeaf Analgesic Infusion Catheter & Wound Drain (clinicaltrials.gov) - Jan 22, 2016
P=N/A, N=0, Withdrawn, Sponsor: Vital 5, LLC
N=30 --> 60 N=60 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Nov 2016 --> Jan 2016
- || Palexia RP (tapentadol extended release) / Assertio, J&J, Grunenthal, Collegium Pharma
New P3 trial: Depot-opioids for Pre- and Postoperative Pain Relief After Primary Knee Arthroplasty.Tapentadol vs Oxycodone vs Placebo (clinicaltrials.gov) - Nov 14, 2015
P3, N=150, Recruiting, Sponsor: St. Olavs Hospital
- || oxycodone controlled release / Generic mfg.
New P2/3 trial: OXYDOPA: Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease (clinicaltrials.gov) - Nov 11, 2015
P2/3, N=75, Not yet recruiting, Sponsor: University Hospital, Toulouse
- || New P3 trial: Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA (clinicaltrials.gov) - Nov 10, 2015
P3, N=128, Recruiting, Sponsor: Stanford University
- oxycodone controlled release / Generic mfg., oxycodone/naloxone ER / Generic mfg.
Enrollment open: Early Postoperative Administration of Oxycodone +/- Naloxone and Duration of Epidural Analgesia (clinicaltrials.gov) - Sep 14, 2015
P4, N=90, Recruiting, Sponsor: University Hospital Inselspital, Berne
N=60 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Nov 2016 --> Jan 2016 Not yet recruiting --> Recruiting
- Gralise (gabapentin) / Alvogen
New trial, HEOR: Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation (clinicaltrials.gov) - Aug 25, 2015
P=N/A, N=30, Recruiting, Sponsor: Roswell Park Cancer Institute
- | oxycodone controlled release / Generic mfg., oxycodone/naloxone ER / Generic mfg.
New P4 trial: Early Postoperative Administration of Oxycodone +/- Naloxone and Duration of Epidural Analgesia (clinicaltrials.gov) - Aug 5, 2015
P4, N=90, Not yet recruiting, Sponsor: University Hospital Inselspital, Berne
- oxycodone controlled release / Generic mfg.
Trial completion, Trial primary completion date: A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients (clinicaltrials.gov) - Jul 9, 2015
P4, N=128, Completed, Sponsor: Mundipharma Korea Ltd
Not yet recruiting --> Recruiting Recruiting --> Completed | Trial primary completion date: Apr 2013 --> Oct 2013
- | oxycodone controlled release / Generic mfg., ibuprofen / Generic mfg.
New P4 trial, Surgery: Pain Management After Cardiac Surgery - Opioids or NSAID (clinicaltrials.gov) - Jun 24, 2015
P4, N=182, Completed, Sponsor: Aalborg Universitetshospital
- Oxecta (oxycodone) / Assertio
Enrollment open, Trial initiation date, Trial primary completion date: Clinical Evaluation of the ReLeaf Analgesic Infusion Catheter & Wound Drain (clinicaltrials.gov) - Jun 17, 2015
P=N/A, N=60, Recruiting, Sponsor: Vital 5, LLC
Recruiting --> Completed | Trial primary completion date: Apr 2013 --> Oct 2013 Not yet recruiting --> Recruiting | Initiation date: Nov 2014 --> Jun 2015 | Trial primary completion date: Nov 2015 --> Nov 2016
- pregabalin / Generic mfg., oxycodone controlled release / Generic mfg.
New trial: Magnesium Oral Supplementation to Reduce Pain Inpatients With Severe Peripheral Arterial Occlusive Disease (clinicaltrials.gov) - May 28, 2015
P=N/A, N=150, Not yet recruiting, Sponsor: Azienda Ospedaliera Spedali Civili di Brescia
- ||| oxycodone ER (PF614) / Ensysce Biosciences
New P1 trial: Study of PF614 Compared to OxyContin (clinicaltrials.gov) - May 27, 2015
P1, N=60, Not yet recruiting, Sponsor: Signature Therapeutics
- New P4 trial: Opioids in Chronic Kidney Disease Patients Undergoing Hemodialysis (clinicaltrials.gov) - May 22, 2015
P4, N=20, Recruiting, Sponsor: Emerio & Lourdes Linares Research and Education Center
- | oxycodone controlled release / Generic mfg.
Trial completion, Enrollment change: Abuse Liability of Controlled-Release Oxycodone Formulations (clinicaltrials.gov) - Jan 9, 2015
P4, N=11, Completed, Sponsor: Centre for Addiction and Mental Health
Not yet recruiting --> Recruiting | Initiation date: Nov 2014 --> Jun 2015 | Trial primary completion date: Nov 2015 --> Nov 2016 Recruiting --> Completed | N=25 --> 11
- |||| oxycodone controlled release / Generic mfg., buprenorphine transdermal / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Norspan Versus Oxycontin as Postoperative Painkiller to Proximal Extracapsular Fractures of the Femur (clinicaltrials.gov) - Dec 9, 2014
P4, N=76, Completed, Sponsor: Vejle Hospital
Recruiting --> Completed | N=25 --> 11 Recruiting --> Completed | N=50 --> 76 | Trial primary completion date: Sep 2013 --> May 2013
- oxycodone controlled release / Generic mfg.
Clinical data: Early Use of Opioid in Radiation Mucositis (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=174, Not yet recruiting, Sponsor: Affiliated Tumor Hospital of Guangzhou Medical University
- Oxecta (oxycodone) / Assertio
Clinical: Clinical Evaluation of the ReLeaf Analgesic Infusion Catheter & Wound Drain (clinicaltrials.gov) - Nov 18, 2014
P=N/A, N=60, Not yet recruiting, Sponsor: Vital 5, LLC
- | oxycodone controlled release / Generic mfg.
Trial completion: A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers (clinicaltrials.gov) - Nov 13, 2014
P1, N=24, Completed, Sponsor: GL Pharm Tech Corporation
Recruiting --> Completed | N=50 --> 76 | Trial primary completion date: Sep 2013 --> May 2013 Not yet recruiting --> Completed
- ||||||| oxycodone controlled release / Generic mfg., oxycodone/naloxone ER / Generic mfg.
Trial completion, Enrollment change: A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain (clinicaltrials.gov) - Nov 7, 2014
P3, N=450, Completed, Sponsor: Purdue Pharma LP
Not yet recruiting --> Completed Active, not recruiting --> Completed | N=900 --> 450
- ||||||| oxycodone controlled release / Generic mfg., oxycodone/naloxone ER / Generic mfg.
Trial completion, Enrollment change: Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain (clinicaltrials.gov) - Nov 7, 2014
P3, N=455, Completed, Sponsor: Purdue Pharma LP
Active, not recruiting --> Completed | N=900 --> 450 Active, not recruiting --> Completed | N=600 --> 455
- | Belbuca (buprenorphine BEMA) / Collegium Pharma
Trial completion, Trial primary completion date: Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film (clinicaltrials.gov) - Nov 3, 2014
P2, N=41, Completed, Sponsor: Endo Pharmaceuticals
Active, not recruiting --> Completed | N=600 --> 455 Recruiting --> Completed | Trial primary completion date: Feb 2014 --> Jul 2014
- ||||||| oxycodone controlled release / Generic mfg.
Trial completion: Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids (clinicaltrials.gov) - Aug 28, 2014
P3, N=155, Completed, Sponsor: Purdue Pharma LP
Recruiting --> Completed | Trial primary completion date: Feb 2014 --> Jul 2014 Recruiting --> Completed
- |||| oxycodone controlled release / Generic mfg., oxycodone/naloxone ER / Generic mfg.
Trial primary completion date: A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain (clinicaltrials.gov) - Aug 4, 2014
P3, N=900, Active, not recruiting, Sponsor: Purdue Pharma LP
Recruiting --> Completed Trial primary completion date: Mar 2015 --> Oct 2014
- |||| oxycodone controlled release / Generic mfg., oxycodone/naloxone ER / Generic mfg.
Trial primary completion date: Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain (clinicaltrials.gov) - Aug 4, 2014
P3, N=600, Active, not recruiting, Sponsor: Purdue Pharma LP
Trial primary completion date: Mar 2015 --> Oct 2014 Trial primary completion date: Mar 2015 --> Oct 2014
- |||| cebranopadol (TRN-228) / Tris Pharma
Trial completion: Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain (clinicaltrials.gov) - Jul 8, 2014
P2, N=619, Completed, Sponsor: Forest Laboratories
Trial primary completion date: Mar 2015 --> Oct 2014 Active, not recruiting --> Completed
- |||| oxycodone controlled release / Generic mfg.
Trial primary completion date: Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids (clinicaltrials.gov) - Jun 19, 2014
P3, N=154, Recruiting, Sponsor: Purdue Pharma LP
Active, not recruiting --> Completed Trial primary completion date: Jun 2014 --> Sep 2014
- | oxycodone controlled release / Generic mfg., naproxen / Generic mfg.
New P4 trial, Surgery: Controlled-Release Oxycodone Versus Naproxen at Home After Ambulatory Surgery: A Randomized Controlled Trial (clinicaltrials.gov) - May 29, 2014
P4, N=105, Completed, Sponsor: Maastricht University Medical Center
- ||||| oxycodone controlled release / Generic mfg., oxycodone/naloxone ER / Generic mfg.
Enrollment closed: A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain (clinicaltrials.gov) - May 15, 2014
P3, N=900, Active, not recruiting, Sponsor: Purdue Pharma LP
Trial primary completion date: Jun 2014 --> Sep 2014 Recruiting --> Active, not recruiting
- ||||| oxycodone controlled release / Generic mfg., oxycodone/naloxone ER / Generic mfg.
Enrollment closed: Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain (clinicaltrials.gov) - May 15, 2014
P3, N=600, Active, not recruiting, Sponsor: Purdue Pharma LP
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- || oxycodone controlled release / Generic mfg.
Trial completion: Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001 (clinicaltrials.gov) - May 15, 2014
P3, N=23, Completed, Sponsor: Purdue Pharma LP
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | oxycodone controlled release / Generic mfg.
Enrollment change: Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001 (clinicaltrials.gov) - May 15, 2014
P3, N=32, Active, not recruiting, Sponsor: Purdue Pharma LP
Active, not recruiting --> Completed N=135 --> 32
- oxycodone controlled release / Generic mfg.
Trial completion date: Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001 (clinicaltrials.gov) - May 6, 2014
P3, N=32, Active, not recruiting, Sponsor: Purdue Pharma LP
N=135 --> 32 Trial completion date: Apr 2014 --> May 2014
- oxycodone controlled release / Generic mfg.
New P4 trial: Abuse Liability of Controlled-Release Oxycodone Formulations (clinicaltrials.gov) - Mar 31, 2014
P4, N=25, Recruiting, Sponsor: Centre for Addiction and Mental Health
- | oxycodone controlled release / Generic mfg.
Enrollment closed: Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001 (clinicaltrials.gov) - Jan 22, 2014
P3, N=32, Active, not recruiting, Sponsor: Purdue Pharma LP
Trial completion date: Apr 2014 --> May 2014 Recruiting --> Active, not recruiting
- ||| cebranopadol (TRN-228) / Tris Pharma
Enrollment closed: Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain (clinicaltrials.gov) - Dec 15, 2013
P2, N=600, Active, not recruiting, Sponsor: Forest Laboratories
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- ||||| oxycodone controlled release / Generic mfg., oxycodone/naloxone ER / Generic mfg.
Enrollment change: Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain (clinicaltrials.gov) - Oct 29, 2013
P3, N=600, Recruiting, Sponsor: Purdue Pharma LP
Recruiting --> Active, not recruiting N=900 --> 600
- || Movicol (AJG555) / Mochida, Eisai
New P2/3 trial, Adverse events: A new way of evaluating the adverse effects of opioids on the gut. En ny måde at evaluere opioiders bivirkninger på mavetarmsystemet. (EUDRACT) - Jul 31, 2013
P2/3, N=70, Ongoing, Sponsor: Mech-Sense, Aalborg University Hospital
- | Belbuca (buprenorphine BEMA) / Collegium Pharma
Enrollment open: Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film (clinicaltrials.gov) - Jul 17, 2013
P2, N=48, Recruiting, Sponsor: Endo Pharmaceuticals
N=900 --> 600 Not yet recruiting --> Recruiting
- | Belbuca (buprenorphine BEMA) / Collegium Pharma
New P2 trial: Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film (clinicaltrials.gov) - Jun 4, 2013
P2, N=48, Recruiting, Sponsor: Endo Pharmaceuticals